CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD‐1 Expression via the Wnt/ <i>β</i> ‐Catenin Pathway
<i>CLEC4G</i> modulates the <i>PD-1</i> expression of HCC cells through the Wnt/<i>β</i>-catenin pathway, thereby reversing the resistance to Lenva.
Authors
- Keke Xiao (ORCID: https://orcid.org/0000-0001-8578-9773)
- Yan Jin (ORCID: https://orcid.org/0000-0002-7668-4803)
- Bin He (ORCID: https://orcid.org/0000-0003-1727-8132)
- Guang-Shuai He (ORCID: https://orcid.org/0009-0002-3866-2432)
Institutions
- Daye People's Hospital (CN)
Publication Details
- Journal
- International Journal of Genomics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/ijog/9225945
- Primary Topic
- Wnt/β-catenin signaling in development and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00